Skip to main content
Figure 2 | BMC Public Health

Figure 2

From: Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study

Figure 2

Overall MCV1 Coverage by Indicator. Note: MCV1 coverage based on all available data and sample size varies by indicator. ‘Oral fluid adjusted for seroconversion’ assumes 85% of vaccinated children seroconverted. ‘Oral fluid, adjusted for seroconversion and assay sensitivity/specificity’ assumes 85% seroconversion and adjusts for the sensitivity (93%) and specificity (98%) of the assays, as reported by the manufacturer.

Back to article page